All 1 tracked stories fall under one category: medical-devices. Abbott Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention MiniMed Group, Inc., all published on August 22, 2026.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about MiniMed Group, Inc.
All 1 tracked stories fall under one category: medical-devices. Abbott Laboratories is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. Each carries 2 original sources on average. We currently track 1 Healthcare story that mention MiniMed Group, Inc., all published on August 22, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 3 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering MiniMed Group, Inc.. Shared-story counts are live from our verified record — not editorial picks.
MiniMed scheduled to report fiscal Q1 2027 results
MiniMed Group will report its fiscal Q1 2027 results, the first earnings check after the MiniMed Flex U.S. launch.
MiniMed announces U.S. commercial shipping of MiniMed Flex with Abbott Instinct
MiniMed Group says its Flex automated insulin delivery system is now shipping in the U.S. integrated with Abbott's Instinct 15-day continuous glucose sensor.
The Abbott-MiniMed Flex integration is now shipping in the U.S., pairing Abbott's 15-day Instinct sensor with MiniMed's smallest app-controlled insulin pump. Clinicians and health systems gain a real-world data point of 80% Time in Range, while payers will weigh the combined system's value against entrenched CGM and AID competitors.